At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Size Sorted Ascending View  
4 barrett, m james Mar 9, 2012 25.3 KB View HTML View PDF View XLS  
4 raab, michael Jun 15, 2012 24.1 KB View HTML View PDF View XLS  
4 topper, james n Jun 15, 2012 24.2 KB View HTML View PDF View XLS  
4 sblendorio, glenn Jun 15, 2012 24.1 KB View HTML View PDF View XLS  
4 raab, michael Jun 11, 2008 24.4 KB View HTML View PDF View XLS  
4 mcglynn, margaret g Jun 15, 2012 23.9 KB View HTML View PDF View XLS  
4 barer, sol j Jun 11, 2009 19.6 KB View HTML View PDF View XLS  
4 barer, sol j Jun 16, 2010 19.6 KB View HTML View PDF View XLS  
4 barer, sol j Jun 14, 2011 24.5 KB View HTML View PDF View XLS  
4 hayden, donald j jr Jun 11, 2009 19.6 KB View HTML View PDF View XLS  
4 hayden, donald j jr Jun 16, 2010 19.6 KB View HTML View PDF View XLS  
4 hayden, donald j jr Jun 14, 2011 24.5 KB View HTML View PDF View XLS  
4 essner, robert Jul 11, 2012 24.5 KB View HTML View PDF View XLS  
4 hayden, donald j jr Jun 20, 2011 24.6 KB View HTML View PDF View XLS  
4 crowley, john f Aug 28, 2008 20.6 KB View HTML View PDF View XLS  
4 raab, michael Jun 11, 2009 19.5 KB View HTML View PDF View XLS  
4 raab, michael Jun 16, 2010 19.5 KB View HTML View PDF View XLS  
4 raab, michael Jun 14, 2011 24.5 KB View HTML View PDF View XLS  
4 sblendorio, glenn Jun 11, 2009 19.5 KB View HTML View PDF View XLS  
4 topper, james n Jun 11, 2009 19.7 KB View HTML View PDF View XLS  
Showing 61-80 of 458 Page: 1 2 3 4 5 6 7 8 ... 23  Previous 20 | Next 20

Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy